Paul Tudor Jones Lannett CO Inc Transaction History

Tudor Investment Corp Et Al

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.63 $1,372 - $1,879	-2,984 Reduced 2.35%	124,250 $56,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.93 $391 - $735	-251 Reduced 0.2%	127,234 $206,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.83 $10,537 - $17,489	3,621 Added 2.92%	127,485 $382,000
Q2 2021 Aug 16, 2021	BUY	$4.17 - $5.74 $516,512 - $710,979	123,864 New	123,864 $578,000
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $105,935 - $191,178	-30,885 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.75 - $14.5 $51,466 - $157,107	10,835 Added 54.04%	30,885 $147,000
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.45 $266,665 - $349,872	20,050 New	20,050 $273,000
Q1 2018 May 15, 2018	SELL	$14.7 - $24.95 $137,165 - $232,808	-9,331 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$19.9 - $29.25 $185,686 - $272,931	9,331	9,331 $216,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.